Adeno-associated vector compositions for expression of Factor VIII
First Claim
1. A pharmaceutical composition comprising a recombinant adeno-associated virus (AAV) virion comprising a nucleotide sequence encoding a functional Factor VIII protein, wherein said recombinant adeno-associated virus virion lacks AAV rep and cap genes, wherein said Factor VIII protein is B domain-deleted, and wherein said nucleotide sequence comprises SEQ ID NO:
- 13.
2 Assignments
0 Petitions
Accused Products
Abstract
One form of a composition has two types of recombinant adeno-associated virus. The first type encodes a portion of Factor VIII operably linked to an expression control element; and the second type encodes a different portion of Factor VIII operably linked to an expression control element. The first and second nucleotide sequences collectively encode a functional Factor VIII protein. Another form of the composition is a recombinant adeno-associated virus containing a nucleotide sequence encoding functional Factor VIII light or heavy chain operably linked to a tissue-specific promoter.
56 Citations
2 Claims
-
1. A pharmaceutical composition comprising a recombinant adeno-associated virus (AAV) virion comprising a nucleotide sequence encoding a functional Factor VIII protein, wherein said recombinant adeno-associated virus virion lacks AAV rep and cap genes, wherein said Factor VIII protein is B domain-deleted, and wherein said nucleotide sequence comprises SEQ ID NO:
- 13.
-
2. A pharmaceutical composition comprising a recombinant adeno-associated virus (AAV) virion comprising a nucleotide sequence encoding a functional Factor VIII protein, wherein said recombinant adeno-associated virus virion lacks AAV rep and cap genes, wherein said Factor VIII protein is B domain-deleted, and, wherein said nucleotide sequence comprises SEQ ID NO:
- 14.
Specification